Antibacterial Resistance Leadership Group (ARLG) begins clinical trial of phage therapy for cystic fibrosisThe trial is evaluating whether the bacteriophage, or “phage,” therapy is safe and able to reduce the amount of bacteria in the lungs of volunteersLatest UpdatesResearch By EP News Bureau On Oct 6, 2022 0 166 Share